Journal article
Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction cycles
Abstract
BACKGROUND: Until recently, the main source of exogenous follicle stimulating hormone (FSH) for therapeutic use in infertility had been the urine of postmenopausal women. New developments have resulted in the production of FSH in vitro by recombinant DNA technology. The extremely high purity and batch-to-batch consistency of recombinant FSH (rFSH) make it an attractive alternative to urinary FSH (uFSH).
OBJECTIVES: To conduct a systematic …
Authors
Daya S; Gunby JL
Journal
, , No. 3,
Publisher
Wiley
Publication Date
2000
DOI
10.1002/14651858.cd002810
ISSN
1465-1858